Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category
Sunil Pasricha; Gurudutt Gupta; Ritu Garg; Anila Sharma; Jatin S. Gandhi; Garima Durga; Meenakshi Kamboj; Shrruti Grover; Anurag Mehta
Author Information: Department of Histopathology and Cytopathology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.